ZJYL
Jin Medical International Ltd.
NASDAQ · Healthcare · Medical - Instruments & Supplies · CN
$2.11
+1.44%Year over year
Reported trailing growth
- Revenue
- -13.6%
- EBITDA
- -69.0%
- EBIT
- -78.6%
- EPS
- -35.9%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +2.5%
- EBITDA
- -32.4%
- EBIT
- -34.2%
- Net income
- -23.9%
- EPS
- -27.9%
- Free cash flow
- -59.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026